# US 2023/0414669 A1 · Production method for therapeutic agent for arthrosis, and therapeutic agent for arthrosis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0414669 A1
- Document ID: US20230414669A1
- Status: Published application
- Kind: A1
- Application number: 18/463,631
- Filed: 2023-09-08
- Published: 2023-12-28
- Earliest claimed: 2021-03-12
- Assignees: FUJIFILM Corporation; National University Corporation Tokyo Medical and Dental University
- Applicants: FUJIFILM Corporation; National University Corporation Tokyo Medical and Dental University
- Inventors: Kentaro NAKAMURA; Shunsuke TOMINAGA; Ichiro SEKIYA; Mitsuru MIZUNO; Hisako KATANO; Nobutake OZEKI
- Web page: https://patentgrep.com/patent/US20230414669A1

## CPC

- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- C12N 5/0668: {Mesenchymal stem cells from other natural sources}
- G01N 1/4044: {by chemical techniques; Digestion; Chemical decomposition}
- G01N 15/1433: using image recognition
- G01N 15/1468: {with spatial resolution of the texture or inner structure of the particle}
- G06T 7/0012: {Biomedical image inspection}
- G06T 7/60: Analysis of geometric attributes
- G01N 2015/1006: {for cytology}
- G01N 2015/1486: {Counting the particles}
- G06T 2207/30024: Cell structures in vitro; Tissue sections in vitro
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL

## Abstract

There are provided a production method for a therapeutic agent for arthrosis, in which a population including a plurality of mesenchymal stem cells being cultured is imaged to acquire a cell image, the cell image is analyzed to derive density information on the mesenchymal stem cells in the cell image, colonies, which are formed by the mesenchymal stem cells in the population, are detected based on the density information, and the population is sorted based on at least one of an average colony size or a colony forming unit, which is derived from the detected colonies, and provided a therapeutic agent for arthrosis, which is produced by the production method for a therapeutic agent for arthrosis.

## Claims

### Claim 1

A production method for a therapeutic agent for arthrosis, comprising:
imaging a population including a plurality of mesenchymal stem cells being cultured, to acquire a cell image;
analyzing the cell image to derive density information on the mesenchymal stem cells in the cell image;
detecting colonies, which are formed by the mesenchymal stem cells in the population, based on the density information; and
sorting the population based on at least one of an average colony size or a colony forming unit, which is derived from the detected colonies.

### Claim 2 (depends on 1)

The production method for a therapeutic agent for arthrosis according to claim 1,
wherein the density information is an estimated density distribution of the mesenchymal stem cells in the cell image, which is derived from kernel density estimation.

### Claim 3 (depends on 2)

The production method for a therapeutic agent for arthrosis according to claim 2,
wherein the detection of the colonies is carried out by carrying out a mean-shift with reference to the estimated density distribution and detecting, as the colony, a collection of the mesenchymal stem cells, which converges to the same maximal point in the estimated density distribution.

### Claim 4 (depends on 1)

The production method for a therapeutic agent for arthrosis according to claim 1,
wherein the detection of the colonies is carried out on a 4th day to a 6th day from a culture start date, and
the sorting of the population is carried out by sorting a population that satisfies at least one of the following condition a1) or b1),
a1) the average colony size of the mesenchymal stem cells included in the population at any time point of the 4th day to the 6th day from the culture start date start date is 0.740 mm or more, or
b1) the colony forming unit of the mesenchymal stem cells included in the population at any time point of the 4th day to the 6th day from the culture start date is 0.250 units/mm2 or more.

### Claim 5 (depends on 1)

The production method for a therapeutic agent for arthrosis according to claim 1,
wherein the mesenchymal stem cells are obtained by treating a biological tissue with an enzyme.

### Claim 6 (depends on 5)

The production method for a therapeutic agent for arthrosis according to claim 5,
wherein in the treatment of the biological tissue with an enzyme, an enzyme mixture containing at least one kind of collagenase and at least one kind of neutral protease is used.

### Claim 7 (depends on 5)

The production method for a therapeutic agent for arthrosis according to claim 5,
wherein in the treatment of the biological tissue with an enzyme, a ratio of a using amount of the biological tissue to a using amount of the enzyme is 10 to 1,000 on a mass basis.

### Claim 8 (depends on 5)

The production method for a therapeutic agent for arthrosis according to claim 5,
wherein the mesenchymal stem cells are obtained by washing a tissue digestion solution which is obtained by the treatment of the biological tissue with an enzyme until a residual enzyme concentration in a supernatant is 0.5 ng/mL or less.

### Claim 9 (depends on 1)

The production method for a therapeutic agent for arthrosis according to claim 1,
wherein the mesenchymal stem cells are a synovium-derived cell.

### Claim 10 (depends on 1)

The production method for a therapeutic agent for arthrosis according to claim 1,
wherein the mesenchymal stem cells are human-derived cells.

### Claim 11 (depends on 1)

A therapeutic agent for arthritis, which is produced by the production method for a therapeutic agent for arthrosis according to claim 1.
